share_log

Assessing Precigen: Insights From 5 Financial Analysts

Assessing Precigen: Insights From 5 Financial Analysts

評估Precigen:5名財務分析師的見解
Benzinga ·  08/15 15:01
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Precigen (NASDAQ:PGEN) in the last three months.
在看好和看淡之間提供多元的觀點,過去3個月,5位分析師已對Precigen(納斯達克:PGEN)發佈了評級。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖,顯示了過去30天的不同情緒,並將其與前幾個月進行比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $8.2, with a high estimate of $14.00 and a low estimate of $4.00. A 12.77% drop is evident in the current average compared to the previous average price target of $9.40.
分析師對12個月價格目標的評估提供了額外的見解,顯示平均目標爲8.2美元,最高估計爲14.00美元,最低估計爲4.00美元。當前平均值比之前的平均價格目標9.40美元下降了12.77%。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀:詳細解析
An in-depth analysis of...
針對最近分...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論